logo

For the Inventor, By the Inventor

Chicago, IL, United States of America

Shutsung Liao

This inventor holds 13 USPTO granted patents and 4 published patent applications. Top assignees: Arch Development Corporation, The University of Chicago. Active years: 1993-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shutsung Liao. Retrieved from https://idiyas.com/inventor/shutsung-liao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 69.2

Average Co-Inventor Count = 2.3

ph-index = 8

Forward Citations = 352(Granted Patents)


Company Filing History:

goldMedal11 out of 349 
 
Arch Development Corporation
 patents
silverMedal2 out of 965 
 
The University of Chicago
 patents

Years Active: 1993-2014

Loading Chart...
13 patents (USPTO):Explore Patents
1. 8829213 - Liver X receptor agonists (2014-09-09),
2. 7078396 - Method of treating disorder related to high cholesterol concentration (2006-07-18),
3. 7012069 - Liver X receptor agonists (2006-03-14),
4. 6696484 - Method and compositions for regulation of 5-alpha reductase activity (2004-02-24),
5. 6645955 - 3,6-dihydroxy-24-amidyl steroid derivatives (2003-11-11),
6. 6610749 - Polyhydroxylated benzene-containing compounds (2003-08-26),
7. 6576660 - Methods and compositions for regulation of 5-&agr;-reductase activity (2003-06-10),
8. 5639616 - Isolated nucleic acid encoding a ubiquitous nuclear receptor (1997-06-17),
9. 5614620 - DNA binding proteins including androgen receptor (1997-03-25),
10. 5605929 - Methods and compositions for inhibiting 5.alpha.-reductase activity (1997-02-25),
11. 5480913 - Anti-androgen compounds (1996-01-02),
12. 5422371 - Methods and compositions for inhibiting 5.alpha.-reductase activity (1995-06-06),
13. 5208263 - Anti-androgen compounds (1993-05-04),

Title: Shutsung Liao: Innovator in Cholesterol Management and Disease Treatment

Introduction

Shutsung Liao is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of medical science. He holds a total of 13 patents, focusing primarily on compounds that target various health disorders, including high cholesterol and related diseases. His innovative work has the potential to impact the treatment of conditions such as cancer, diabetes, and Alzheimer's disease.

Latest Patents

Among his latest patents, Liao has developed liver X receptor agonists, which are compounds designed to lower blood cholesterol levels. These compounds are defined by a specific formula, where R, A, D, X, Y, and Z are detailed in the specification. Additionally, he has disclosed methods for using these compounds to treat a range of disorders associated with high cholesterol concentrations. His work includes methods, kits, combinations, and compositions aimed at treating conditions where an activator of liver X alpha is indicated.

Career Highlights

Shutsung Liao has had a distinguished career, working with notable organizations such as Arch Development Corporation and the University of Chicago. His experience in these institutions has allowed him to advance his research and develop innovative solutions to pressing health issues.

Collaborations

Liao has collaborated with esteemed colleagues, including Richard Hiipakka and Ching Song. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his inventions.

Conclusion

Shutsung Liao's work exemplifies the intersection of innovation and healthcare, particularly in the management of cholesterol-related disorders. His patents and research continue to pave the way for advancements in medical treatments, showcasing the importance of innovation in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…